The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 19, 2025
Filed:
Nov. 10, 2021
Applicants:
Alnylam Pharmaceuticals, Inc., Cambridge, MA (US);
Vir Biotechnology, Inc., San Francisco, CA (US);
Inventors:
Akin Akinc, Needham, MA (US);
James D. Mcininch, Burlington, MA (US);
Yesseinia Anglero-Rodriguez, Cambridge, MA (US);
Mark K. Schlegel, Boston, MA (US);
Christy M. Hebner, San Francisco, CA (US);
Florian A. Lempp, San Francisco, CA (US);
Assignees:
Alnylam Pharmaceuticals, Inc., Cambridge, MA (US);
Vir Biotechnology, Inc., San Francisco, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12N 15/1131 (2013.01); C12N 2310/14 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/322 (2013.01); C12N 2310/3515 (2013.01);
Abstract
The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the coronavirus genome. The invention also relates to methods of using such RNAi agents to inhibit expression of a coronavirus genome and to methods of treating or preventing a coronavirus-associated disease in a subject.